We've found
8,177
archived clinical trials in
Orthopedic
We've found
8,177
archived clinical trials in
Orthopedic
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
Updated: 4/11/2016
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
ClinicCompanion. Compared to the Use of a Goniometer
Updated: 4/13/2016
A Study of Effectiveness of clinicCompanion. Compared to the Use of a Goniometer for Range of Motion Measurement.
Status: Enrolling
Updated: 4/13/2016
ClinicCompanion. Compared to the Use of a Goniometer
Updated: 4/13/2016
A Study of Effectiveness of clinicCompanion. Compared to the Use of a Goniometer for Range of Motion Measurement.
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Updated: 4/13/2016
A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
The Effect of Balance Training on Unloading Reaction in Individuals With Functional Ankle Instability
Updated: 4/15/2016
The Effect of Balance Training on Unloading Reaction in Individuals With Functional Ankle Instability
Status: Enrolling
Updated: 4/15/2016
The Effect of Balance Training on Unloading Reaction in Individuals With Functional Ankle Instability
Updated: 4/15/2016
The Effect of Balance Training on Unloading Reaction in Individuals With Functional Ankle Instability
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Insights Into Deep Brain Stimulation (DBS) for Cervical Dystonia
Updated: 4/21/2016
Pathophysiological Insights Into STN DBS for Primary Cervical Dystonia
Status: Enrolling
Updated: 4/21/2016
Insights Into Deep Brain Stimulation (DBS) for Cervical Dystonia
Updated: 4/21/2016
Pathophysiological Insights Into STN DBS for Primary Cervical Dystonia
Status: Enrolling
Updated: 4/21/2016
Click here to add this to my saved trials
C7-T1 Epidural Steroid Injections Versus Targeted Injection Via Cervical Epidural Catheter for Treatment of Cervical Radicular Pain
Updated: 4/25/2016
A Prospective Randomized Controlled Trial of Standardized C7-T1 Epidural Steroid Injections Versus Targeted Injection Via Cervical Epidural Catheter for the Treatment of Cervical Radicular Pain
Status: Enrolling
Updated: 4/25/2016
C7-T1 Epidural Steroid Injections Versus Targeted Injection Via Cervical Epidural Catheter for Treatment of Cervical Radicular Pain
Updated: 4/25/2016
A Prospective Randomized Controlled Trial of Standardized C7-T1 Epidural Steroid Injections Versus Targeted Injection Via Cervical Epidural Catheter for the Treatment of Cervical Radicular Pain
Status: Enrolling
Updated: 4/25/2016
Click here to add this to my saved trials
Neurostimulation in Temporomandibular Disorders (TMD) Patients
Updated: 4/25/2016
Randomized Blinded Placebo-Controlled Clinical Trial of Caloric Vestibular Neurostimulation in Patients With Chronic TMD
Status: Enrolling
Updated: 4/25/2016
Neurostimulation in Temporomandibular Disorders (TMD) Patients
Updated: 4/25/2016
Randomized Blinded Placebo-Controlled Clinical Trial of Caloric Vestibular Neurostimulation in Patients With Chronic TMD
Status: Enrolling
Updated: 4/25/2016
Click here to add this to my saved trials
A Randomized Double-Blind Placebo Controlled Trial to Determine the Status of Post Knee Chondroplasty Patients Administered Theramine Versus Placebo in Addition to Post Surgery Analgesics
Updated: 5/4/2016
A Randomized Double-Blind Placebo Controlled Trial to Determine the Status of Post Knee Chondroplasty Patients Administered Theramine Versus Placebo in Addition to Post Surgery Analgesics
Status: Enrolling
Updated: 5/4/2016
A Randomized Double-Blind Placebo Controlled Trial to Determine the Status of Post Knee Chondroplasty Patients Administered Theramine Versus Placebo in Addition to Post Surgery Analgesics
Updated: 5/4/2016
A Randomized Double-Blind Placebo Controlled Trial to Determine the Status of Post Knee Chondroplasty Patients Administered Theramine Versus Placebo in Addition to Post Surgery Analgesics
Status: Enrolling
Updated: 5/4/2016
Click here to add this to my saved trials
Shilla Growth Permitting Spinal Instrumentation System for Treatment of Scoliosis in the Immature Spine
Updated: 5/4/2016
Use of the Shilla Growth Permitting Spinal Instrumentation System/Technique for the Treatment of Scoliosis in the Immature Spine
Status: Enrolling
Updated: 5/4/2016
Shilla Growth Permitting Spinal Instrumentation System for Treatment of Scoliosis in the Immature Spine
Updated: 5/4/2016
Use of the Shilla Growth Permitting Spinal Instrumentation System/Technique for the Treatment of Scoliosis in the Immature Spine
Status: Enrolling
Updated: 5/4/2016
Click here to add this to my saved trials
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
Updated: 5/5/2016
Tocilizumab in Chronic GVHD Refractory to at Least Two Prior Therapies
Status: Enrolling
Updated: 5/5/2016
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
Updated: 5/5/2016
Tocilizumab in Chronic GVHD Refractory to at Least Two Prior Therapies
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
Updated: 5/5/2016
Tocilizumab in Chronic GVHD Refractory to at Least Two Prior Therapies
Status: Enrolling
Updated: 5/5/2016
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
Updated: 5/5/2016
Tocilizumab in Chronic GVHD Refractory to at Least Two Prior Therapies
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
Updated: 5/5/2016
Tocilizumab in Chronic GVHD Refractory to at Least Two Prior Therapies
Status: Enrolling
Updated: 5/5/2016
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
Updated: 5/5/2016
Tocilizumab in Chronic GVHD Refractory to at Least Two Prior Therapies
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
Updated: 5/5/2016
Tocilizumab in Chronic GVHD Refractory to at Least Two Prior Therapies
Status: Enrolling
Updated: 5/5/2016
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
Updated: 5/5/2016
Tocilizumab in Chronic GVHD Refractory to at Least Two Prior Therapies
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
Updated: 5/5/2016
Tocilizumab in Chronic GVHD Refractory to at Least Two Prior Therapies
Status: Enrolling
Updated: 5/5/2016
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
Updated: 5/5/2016
Tocilizumab in Chronic GVHD Refractory to at Least Two Prior Therapies
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Phase 1 Study of ACE-083 in Healthy Subjects
Updated: 5/10/2016
A Phase 1, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Local Muscle Injections of ACE-083 in Healthy Postmenopausal Women
Status: Enrolling
Updated: 5/10/2016
Phase 1 Study of ACE-083 in Healthy Subjects
Updated: 5/10/2016
A Phase 1, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Local Muscle Injections of ACE-083 in Healthy Postmenopausal Women
Status: Enrolling
Updated: 5/10/2016
Click here to add this to my saved trials
HemoSonics-UVA Spinal Surgery
Updated: 5/10/2016
HemoSonics-UVA Spinal Surgery Clinical Study Protocol
Status: Enrolling
Updated: 5/10/2016
HemoSonics-UVA Spinal Surgery
Updated: 5/10/2016
HemoSonics-UVA Spinal Surgery Clinical Study Protocol
Status: Enrolling
Updated: 5/10/2016
Click here to add this to my saved trials
Effects of a Resistance Training Program in Older Women With Sarcopenia
Updated: 5/10/2016
Effects of a Resistance Training Program in Older Women With Sarcopenia
Status: Enrolling
Updated: 5/10/2016
Effects of a Resistance Training Program in Older Women With Sarcopenia
Updated: 5/10/2016
Effects of a Resistance Training Program in Older Women With Sarcopenia
Status: Enrolling
Updated: 5/10/2016
Click here to add this to my saved trials
Ranolazine for the Treatment of Chest Pain in HCM Patients
Updated: 5/11/2016
Ranolazine for the Treatment of Angina in Hypertrophic Cardiomyopathy Investigation
Status: Enrolling
Updated: 5/11/2016
Ranolazine for the Treatment of Chest Pain in HCM Patients
Updated: 5/11/2016
Ranolazine for the Treatment of Angina in Hypertrophic Cardiomyopathy Investigation
Status: Enrolling
Updated: 5/11/2016
Click here to add this to my saved trials
Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study
Updated: 5/12/2016
Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study
Status: Enrolling
Updated: 5/12/2016
Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study
Updated: 5/12/2016
Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study
Status: Enrolling
Updated: 5/12/2016
Click here to add this to my saved trials
Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients
Updated: 5/17/2016
Columbia SMA Project: 4-AP as a Potential SMA Therapeutic Agent and Biological Mechanisms of Action
Status: Enrolling
Updated: 5/17/2016
Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients
Updated: 5/17/2016
Columbia SMA Project: 4-AP as a Potential SMA Therapeutic Agent and Biological Mechanisms of Action
Status: Enrolling
Updated: 5/17/2016
Click here to add this to my saved trials
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Updated: 5/17/2016
A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures
Status: Enrolling
Updated: 5/17/2016
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Updated: 5/17/2016
A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures
Status: Enrolling
Updated: 5/17/2016
Click here to add this to my saved trials
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Updated: 5/17/2016
A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures
Status: Enrolling
Updated: 5/17/2016
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Updated: 5/17/2016
A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures
Status: Enrolling
Updated: 5/17/2016
Click here to add this to my saved trials
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Updated: 5/17/2016
A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures
Status: Enrolling
Updated: 5/17/2016
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Updated: 5/17/2016
A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures
Status: Enrolling
Updated: 5/17/2016
Click here to add this to my saved trials
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Updated: 5/17/2016
A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures
Status: Enrolling
Updated: 5/17/2016
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Updated: 5/17/2016
A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures
Status: Enrolling
Updated: 5/17/2016
Click here to add this to my saved trials
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Updated: 5/17/2016
A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures
Status: Enrolling
Updated: 5/17/2016
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Updated: 5/17/2016
A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures
Status: Enrolling
Updated: 5/17/2016
Click here to add this to my saved trials
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Updated: 5/17/2016
A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures
Status: Enrolling
Updated: 5/17/2016
Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Updated: 5/17/2016
A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures
Status: Enrolling
Updated: 5/17/2016
Click here to add this to my saved trials